CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment

INTRODUCTION: Alzheimer’s disease (AD) is the most prevalent form of dementia with symptoms of deteriorating cognitive functions and memory loss, partially as a result of a decrease in cholinergic neurotransmission. The disease is incurable and treatment with cholinesterase inhibitors (ChEIs) is sym...

Descripción completa

Detalles Bibliográficos
Autores principales: Karami, Azadeh, Darreh-Shori, Taher, Schultzberg, Marianne, Eriksdotter, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426513/
https://www.ncbi.nlm.nih.gov/pubmed/34512307
http://dx.doi.org/10.3389/fnagi.2021.704583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426513/
https://www.ncbi.nlm.nih.gov/pubmed/34512307
http://dx.doi.org/10.3389/fnagi.2021.704583

Ejemplares similares